This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights Molson Coors Beverage, Tyson Foods, Lamb Weston Holdings, Colgate-Palmolive and Church & Dwight
by Zacks Equity Research
Molson Coors Beverage, Tyson Foods, Lamb Weston Holdings, Colgate-Palmolive and Church & Dwight are included in this Analyst Blog.
Molson Coors and KnightSwift have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Molson Coors and KnightSwift have been highlighted as Zacks Bull and Bear of the Day.
Bull Of The Day: Molson Coors (TAP)
by Brian Bolan
This brewer gained a lot of market shares last year and now they are stepping up their ad spend to increase their customer base.
Top 5 Consumer Staples Stocks for a Stable Portfolio in 2024
by Nalak Das
We have narrowed our search to five consumer staples stocks with strong growth potential for 2024. These are: TSN, TAP, CHD, CL, LW.
New Strong Buy Stocks for February 20th
by Zacks Equity Research
APP, CSL, TAP, TW and MSA have been added to the Zacks Rank #1 (Strong Buy) List on February 20, 2024.
TAP vs. NAPA: Which Stock Is the Better Value Option?
by Zacks Equity Research
TAP vs. NAPA: Which Stock Is the Better Value Option?
Is Coca Cola Femsa (KOF) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Coca-Cola FEMSA (KOF) and Molson Coors Brewing (TAP) have performed compared to their sector so far this year.
FEMSA (FMX) Unveils Capital Plan Under Forward Strategy
by Zacks Equity Research
FEMSA (FMX) outlines insights into its FEMSA Forward strategy, providing capital allocation plans for the next few years.
Molson Coors (TAP) Q4 Earnings & Sales Beat on Brand Strength
by Zacks Equity Research
Molson Coors' (TAP) fourth-quarter 2023 results benefit from brand strength and impressive performances across both its business units.
Coca-Cola (KO) Q4 Earnings & Sales Beat Estimates, Rise Y/Y
by Zacks Equity Research
Coca-Cola's (KO) Q4 results reflect gains from pricing actions and a favorable mix. Higher concentrate sales and growth across its operating segments also aid results.
Molson Coors (TAP) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Molson Coors (TAP) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
PepsiCo (PEP) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
PepsiCo's (PEP) Q4 results reflect gains from the mitigation of inflationary pressures through cost-management and revenue-management initiatives. Soft volume hurts the sales performance.
5 Stocks in the S&P 500 ETF to Buy at a Bargain
by Sweta Killa
With the S&P 500 hitting new milestones, valuations are also getting lofty, making investors wary about their investments. For those, we have highlighted five stocks in the S&P 500 ETF that are undervalued, as reflected in their lower P/E ratio than industry peers.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Coca-Cola (KO) Looks Poised for Earnings Beat in Q4
by Zacks Equity Research
Coca-Cola's (KO) Q4 results are expected to reflect gains from strong revenue growth across operating segments, aided by an improved price/mix and higher concentrate sales.
Exploring Analyst Estimates for Molson Coors (TAP) Q4 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Molson Coors (TAP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Top 5 Dividend-Paying Stocks Set to Beat on Earnings Next Week
by Nalak Das
We have narrowed our search to five dividend-paying large-cap stocks that are poised to beat on earnings next week. These are: WM, QSR, TAP, LDOS, VTR.
Molson Coors (TAP) Sees Pricing Gains: Will Q4 Earnings Beat?
by Zacks Equity Research
Molson Coors' (TAP) Q4 results are expected to reflect gains from its pricing actions undertaken to overcome the inflationary environment. A strong brand portfolio and innovation place it well.
Molson Coors Brewing (TAP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Molson Coors (TAP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Monster Beverage (MNST) to Benefit From Energy Drinks Business
by Zacks Equity Research
Monster Beverage (MNST) has been benefiting from the expansion of the energy drinks category and product launches. Product innovation has played a significant role in the company's success.
Will Molson Coors (TAP) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Molson Coors (TAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
TAP or BUD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TAP vs. BUD: Which Stock Is the Better Value Option?
Are Consumer Staples Stocks Lagging Coca Cola Femsa (KOF) This Year?
by Zacks Equity Research
Here is how Coca-Cola FEMSA (KOF) and Molson Coors Brewing (TAP) have performed compared to their sector so far this year.
Are Investors Undervaluing Molson Coors (TAP) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molson Coors (TAP) Surpasses Industry in a Year: What's Ahead?
by Zacks Equity Research
Molson Coors (TAP) looks well-poised on a strong portfolio, revitalization plan and the premiumization of the global portfolio.